We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
-2.66%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$344M
AUM Growth
-$21.8M
Cap. Flow
-$6.55M
Cap. Flow %
-1.9%
Top 10 Hldgs %
27.91%
Holding
117
New
5
Increased
25
Reduced
42
Closed
6

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$2.3M
2
PEP icon
PepsiCo
PEP
+$1.5M
3
PG icon
Procter & Gamble
PG
+$1.48M
4
MSFT icon
Microsoft
MSFT
+$993K
5
AAPL icon
Apple
AAPL
+$591K

Sector Composition

Rank Sector Weight
1 Healthcare 14.56%
2 Technology 13.45%
3 Industrials 11.72%
4 Consumer Staples 10.18%
5 Consumer Discretionary 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADM icon
101
Archer Daniels Midland
ADM
$37.4B
$259K 0.08%
+2,880
New +$224K
A icon
102
Agilent Technologies
A
$39.9B
$248K 0.07%
1,879
BA icon
103
Boeing
BA
$190B
$248K 0.07%
1,300
DIA icon
104
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46.7B
$232K 0.07%
+670
New +$232K
TROW icon
105
T. Rowe Price
TROW
$24.5B
$214K 0.06%
1,418
IWF icon
106
iShares Russell 1000 Growth ETF
IWF
$127B
$210K 0.06%
3,040
GE icon
107
GE Aerospace
GE
$396B
$209K 0.06%
3,676
-332
-8% -$19.8K
IXN icon
108
iShares Global Tech ETF
IXN
$8.77B
$208K 0.06%
3,600
WEC icon
109
WEC Energy
WEC
$35.3B
$207K 0.06%
2,082
MAS icon
110
Masco
MAS
$15.2B
$204K 0.06%
4,000
GD icon
111
General Dynamics
GD
$104B
$202K 0.06%
+840
New +$187K
CLX icon
112
Clorox
CLX
$12.8B
-1,375
Closed -$239K
ITOT icon
113
iShares Core S&P Total US Stock Market ETF
ITOT
$97.3B
-2,684
Closed -$287K
LOW icon
114
Lowe's Companies
LOW
$123B
-980
Closed -$253K
T icon
115
AT&T
T
$158B
-18,566
Closed -$344K
VFC icon
116
VF Corp
VFC
$5.98B
-3,120
Closed -$228K
YUMC icon
117
Yum China
YUMC
$16.3B
-4,320
Closed -$215K

Similar funds

Boston Research & Management's Q1 2022 Portfolio in Review

As of Q1 2022, Boston Research & Management held 117 positions worth $344M, down 5.9% from $366M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Boston Research & Management's Q1 2022 filing shows 5 new, 25 increased, 42 reduced and 6 closed positions. Its largest new stake was Invesco QQQ Trust: 1,170 shares worth $424K. The largest sale was Accenture, an estimated $2.3M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

  • Boston Research & Management's largest Q1 2022 buy was Invesco QQQ Trust: 1,170 shares worth $424K.
  • Boston Research & Management added most to JPMorgan Chase in Q1 2022, an estimated $1.19M increase.
  • Boston Research & Management's biggest Q1 2022 reduction was Accenture, cutting an estimated $2.3M.
  • Boston Research & Management fully exited AT&T in Q1 2022, selling an estimated $344K.
  • Boston Research & Management's ten largest holdings make up 28% of its $344M portfolio in Q1 2022.
  • Boston Research & Management opened 5 new positions and closed 6 in Q1 2022.
  • Boston Research & Management's portfolio value fell 5.9% quarter-over-quarter to $344M.

Based on Boston Research & Management's 13F filing for Q1 2022, filed 12 May 2022.